I am Biotech

Today, BIO is launching Fight of Our Lives, a national campaign to build understanding of biotechnology, the people behind it, and the life-changing hope it creates for millions - because behind every breakthrough is a story of people, purpose, and the drive to find what comes next.

Biotechnology has transformed what’s possible - but many are still waiting for the next generation of solutions. Fight of Our Lives brings those real stories forward and reinforces what it takes to keep progress moving: a strong, predictable environment where innovation can thrive and reach those who need it most.

Hear the stories. See the impact. Explore the history. And join us in sharing the promise of American biotech - and the fight it will take to preserve it.

Learn more: https://fightofourlives.com/

Day 1 of delivered! Across 10 sessions, leaders examined pressing issues facing our industry - from today’s capital environment and key drivers of renewed M&A activity to the evolving role of venture capital and family offices in strengthening the innovation ecosystem.

Policy priorities were also front and center, including regulatory considerations related to cross-border licensing trends - and trade policy risks shaping deal structures and valuation in an active tariff environment.

Beyond the stage, momentum carried into the hundreds of BIO Partnering® meetings, where investors, executives, and innovators engaged directly on capital formation and strategic collaboration.

On to Day 2!

Rare Disease Week is a reminder of what patient voices can achieve...

This year, the rare disease community helped secure reauthorization of the Rare Pediatric Disease Priority Review Voucher (PPRV) program - preserving a critical pathway for the development of new medicines and treatments.

Because patients raise their voices, progress continues.